Episode 217: March 2020 Retinal Physician Discussion of Extended-Durability Agents in Trial with Dr. Ferhina Ali

Dr. Ferhina Ali joins the program to discuss the March 2020 issue of Retinal Physician (http://www.retinalphysician.com) including a discussion of various extended-durability agents in trial currently.

Financial Disclosures:

Dr. Sridhar: Consultant for Alcon, Alimera, Oxurion, and Regeneron

Dr. Ali: Dr. Ali is a Genentech employee and stock holder and has consulted for Voyant biotherapeutics and Forsight

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.